CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore patent oppositions filed by Novo Nordisk against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Last updated on: Aug 21, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Methods For Controlling Blood Pharmacokinetics Of AntibodiesCHUGAI SEIYAKU KABUSHIKI KAISHAJun 15, 2022
Device For The Oral Delivery Of Therapeutic CompoundsRANI THERAPEUTICSMay 25, 2022
A Method Of Weak Partitioning ChromatographyWYETHFeb 5, 2021
Swallowable Drug Delivery DeviceRANI THERAPEUTICSJan 21, 2021
Therapeutic Agent Preparations For Delivery Into A Lumen Of The Intestinal Tract Using A Swallowable Drug Delivery DeviceINCUBE LABSApr 16, 2020
Swallowable Drug Delivery Device And Methods Of Drug DeliveryINCUBE LABSJul 9, 2019
Antigen-Binding Molecule Capable Of Binding To Two Or More Antigen Molecules RepeatedlyCHUGAI SEIYAKU KABUSHIKI KAISHADec 19, 2018
A Method Of Producing An Antibody Comprising A Human Variable Region And A Rodent Constant Region.REGENERON PHARMACEUTICALSNov 6, 2018

Explore Novo Nordisk's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 21, 2025
Patent NumberGrant DateTitleTotal Oppositions
Jan 8, 2025Propylene Glycol-Containing Peptide Formulations Which Are Optimal For Production And For Use In Injection Devices5
Nov 6, 2024Drug Delivery Injection Pen With Add-On Dose Capturing And Display Module1
Sep 11, 2024Process Of Spray Drying Of Glp-1 Peptide1
May 29, 2024Glp-1 Receptor Agonists In Dementia2
Feb 7, 2024Glp-1 Compositions And Uses Thereof8
Jan 17, 2024Tablets Comprising Glp-1 Agonist And Enteric Coating1
Oct 4, 2023Compositions Of Glp-1 Peptides And Preparation Thereof5
Sep 13, 2023Compositions Comprising A Delivery Agent And Preparation Thereof7
Jul 19, 2023Solid Compositions Comprising A Glp-1 Agonist, A Salt Of N-(8-(2-Hydroxybenzoyl)Amino)Caprylic Acid And A Lubricant4
Jun 7, 2023Stable Semaglutide Compositions And Uses Thereof1

Top competitors of Novo Nordisk

Top competitors of Novo Nordisk based on patent oppositions.